Advertisement
Singapore markets closed

  • Straits Times Index

    3,293.13
    +20.41 (+0.62%)
     

  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     

  • Dow

    38,503.69
    +263.71 (+0.69%)
     

  • Nasdaq

    15,696.64
    +245.33 (+1.59%)
     

  • Bitcoin USD

    66,575.62
    +492.74 (+0.75%)
     

  • CMC Crypto 200

    1,434.56
    +10.46 (+0.73%)
     

  • FTSE 100

    8,084.40
    +39.59 (+0.49%)
     

  • Gold

    2,328.10
    -14.00 (-0.60%)
     

  • Crude Oil

    82.82
    -0.54 (-0.65%)
     

  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     

  • Nikkei

    38,460.08
    +907.92 (+2.42%)
     

  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     

  • FTSE Bursa Malaysia

    1,571.48
    +9.84 (+0.63%)
     

  • Jakarta Composite Index

    7,174.53
    +63.72 (+0.90%)
     

  • PSE Index

    6,572.75
    +65.95 (+1.01%)
     

Global healthcare M&A doubles versus 2014

Reuters

LONDON (Reuters) - Worldwide dealmaking in the healthcare sector has doubled this year compared with the same time in 2014, buoyed by Teva Pharmaceuticals Industries' (TEVA.N) unsolicited $40 billion (26 billion pounds) bid for smaller rival Mylan (MYL.O) this week, Thomson Reuters data shows.

So far this year, deals worth $193.9 billion have been announced in healthcare, the data shows.

Worldwide M&A is up 23 percent year-to-date versus the same period last year, with deals worth $1,186 trillion having been struck so far.

(Reporting By Anjuli Davies; Editing by Pravin Char)